Page 1,106«..1020..1,1051,1061,1071,108..1,1201,130..»

Interleukin Genetics and Renaissance Health Service Corporation Enter into a Preferred Participation Agreement for …

WALTHAM, Mass.--(BUSINESS WIRE)--

Interleukin Genetics, Inc. (ILIU), which is pioneering the use of genetic information for the prevention and improved management of certain chronic conditions of aging, today announced that it has entered into a three year Preferred Participation Agreement with Renaissance Health Service Corporation, and certain of its affiliates and subsidiaries, (collectively RHSC). Pursuant to the Agreement, RHSC has agreed to reimburse Interleukin a fixed price for each PST genetic test that it processes for a customer of RHSC.

Interleukins proprietary PST genetic risk panel for periodontal disease severity and tooth loss susceptibility addresses the need to identify individuals who are at greater risk of severe periodontitis, a primary cause of tooth loss.

We are encouraged by RHSCs efforts to advance personalized health in dentistry through the use of our unique periodontal susceptibility risk test, PST, said Kenneth S. Kornman, CEO, Interleukin Genetics.

About Renaissance Health Service Corporation

Renaissance Health Service Corporation (RHSC) is the parent organization for a family of companies that are leaders in the dental insurance industry. RHSC companies are among the largest and oldest group of dental benefit providers in the United States, covering 11 million people and paying out nearly $3 billion in dental benefits in 2012. Currently, the companies employ approximately 1,200 people, who are located in Indianapolis, Indiana; Sherwood and Little Rock, Arkansas; Louisville, Kentucky; Okemos and Farmington Hills, Michigan; Albuquerque, New Mexico; Raleigh and Charlotte, North Carolina; Columbus and Cleveland, Ohio; and Nashville, Knoxville, and Memphis, Tennessee.

About Interleukin Genetics

Interleukin Genetics, Inc. (ILIU) develops and markets a line of genetic tests under the Inherent Health and PST brands.The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The Company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. Interleukin Genetics flagship products include its proprietary PST genetic risk panel for periodontal disease and tooth loss susceptibility sold through dentists and the Inherent Health Weight Management Genetic Test that identifies the most effective diet and exercise program for an individual based on genetics. Interleukin Genetics is headquartered in Waltham, Mass. and operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). For more information, please visit http://www.ilgenetics.com.

Certain statements contained herein are forward-looking statements. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, risks related to the adequacy of the Companys capital resources and the need for additional funding, that the offering of dental plans by RHSC affiliates that include the PSTtest will be delayed significantly, that RHSC affiliates may not be successful in developing or marketing such dental plans, and that such dental plans may not be accepted by dental customers, as well as the risks and uncertainties described in the Companys annual report on Form 10-K for the year ended December 31, 2011 and other filings with the Securities and Exchange Commission. The Company disclaims any obligation or intention to update these forward-looking statements.

Original post:
Interleukin Genetics and Renaissance Health Service Corporation Enter into a Preferred Participation Agreement for ...

Recommendation and review posted by Bethany Smith

Charlotte family funds research into gene therapy for rare Batten disease

Laura King Edwards was a high school junior when her sister Taylor was born in 1998.

Despite the age difference, they became very close.

When Taylor was 1, Lauras summer job was babysitting, five days a week, 10 hours a day. They spent afternoons curled up on the couch, watching TV or taking naps.

She called me Rar Rar before she could say my name, Laura recalls. I called her T.

Taylor taught herself to read at 3 and excelled in kindergarten. But in first grade, she began having trouble with homework and with her vision. She was diagnosed with retinitis pigmentosa, an inherited disorder that causes a gradual vision loss.

But that turned out to be wrong. In 2006, just three weeks before her eighth birthday, Taylor got an even more devastating diagnosis neuronal ceroid lipofuscinosis, also called Batten disease.

When Laura Googled the words, she read only a few sentences before she started to cry.

Batten disease is a rare, inherited neurodegenerative disease that results in the death of neurons in the brain, retina and central nervous system.

Early symptoms are vision loss, seizures, clumsiness and personality changes. Eventually, it leaves children blind, bedridden and unable to communicate. There is no known cure or effective treatment.

To get the disease, Taylor had to inherit a defective copy of a particular gene from each of her parents. Her sister Laura got one good copy and one bad copy, so shes a carrier, which means shes healthy but could pass the gene on to her children.

Read the original here:
Charlotte family funds research into gene therapy for rare Batten disease

Recommendation and review posted by Bethany Smith

Genetics and Genome-Guided Personalized Medicine in Thailand Part3/3 – Video


Genetics and Genome-Guided Personalized Medicine in Thailand Part3/3
Presented by Professor Wasun Chantratita Director of Pharmacogenomics project under collaboration between Thailand Center of Excellence for Life Sciences, Mahidol University, Bangkok and Head of Virology and Molecular Microbiology, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand The 2nd Meeting of South East Asian Pharmacogenomics Research Network (SEAPharm) Symposium for Genetic and Genome-Guided Personalized Medicine in Asia

By: ThePharmacogenomics

Go here to read the rest:
Genetics and Genome-Guided Personalized Medicine in Thailand Part3/3 - Video

Recommendation and review posted by sam

Myotonic Muscular Dystrophy Before and After Stem Cell Therapy – Video


Myotonic Muscular Dystrophy Before and After Stem Cell Therapy
Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy He is a known case of Myotonic MD with history of gradual onset of progressive lower extremities muscle weakness since age of 25 years. He also has history of delayed milestones. His weakness is progressive in nature. He falls while walking so walks with human support only. He has complaints of early fatigue and slurred speech due to tongue hypertrophy. He has atrophy of proximal muscles of all extremities. He has modified independence in almost all ADL. Neurologically, hypotonic, hyporeflexic. On examination: lower limb distal muscles are 0/5 on MMT while proximal muscles are having 2++/5 on MMT. Upper extremities left side proximal muscles are 1++/5 while right side proximal muscles are 3 #713;/5, distal muscles are 3++/5 in upper extremities. Functionally, modified independence in all ADL. On FIM he scores 99. After Stem Cell Treatment 1. His face looks more fresh. 2. His neck used to fall back previously but now he can control his neck well in each movement. 3. Back muscle strength has improved. 4. Bridging is better now. He can lift his back more up now which he couldn #39;t do at all. 5. His stamina has improved. 6. His shoulder strength has improved. Shoulder shrugging is better now. Active shoulder flexion, range of motion is more now. 7. Side lying to sitting he can do without any support which was not possible before. 8. Drooling of saliva from mouth in night is completely stopped. 9. His legs used ...

By: neurogenbsi

Read more here:
Myotonic Muscular Dystrophy Before and After Stem Cell Therapy - Video

Recommendation and review posted by simmons

Stem Cell Therapy for Autism Part 1 – Video


Stem Cell Therapy for Autism Part 1
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy 1. Angry spells are short lasting than before. Earlier, if he used to be upset for half hour at a stretch, now he calms down in 2 minutes. 2. Did not ask for toothpaste for second time which he used to do daily. 3. He does not insist on bathing 2-3 times a day like before. Now, he takes bath once a day. 4. Visits washroom once in 2-3 hours and then washes his hand normally and leaves the washroom. Earlier, he used to go to washroom every hourly and wash his hand, spill water on his clothes and arms. 5. Eye contact attention span improved. 6. Sitting tolerance improved and attends for 30 mins session. 7. Listening skills and observation skills on demand improved. 8. Screaming behavior reduces when given paper tearing activity. 9. His parents feel his ...

By: neurogenbsi

Here is the original post:
Stem Cell Therapy for Autism Part 1 - Video

Recommendation and review posted by simmons

Stem Cell Therapy for Autism Part 1 Tamil – Video


Stem Cell Therapy for Autism Part 1 Tamil
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy 1. Angry spells are short lasting than before. Earlier, if he used to be upset for half hour at a stretch, now he calms down in 2 minutes. 2. Did not ask for toothpaste for second time which he used to do daily. 3. He does not insist on bathing 2-3 times a day like before. Now, he takes bath once a day. 4. Visits washroom once in 2-3 hours and then washes his hand normally and leaves the washroom. Earlier, he used to go to washroom every hourly and wash his hand, spill water on his clothes and arms. 5. Eye contact attention span improved. 6. Sitting tolerance improved and attends for 30 mins session. 7. Listening skills and observation skills on demand improved. 8. Screaming behavior reduces when given paper tearing activity. 9. His parents feel his ...

By: neurogenbsi

Read the original:
Stem Cell Therapy for Autism Part 1 Tamil - Video

Recommendation and review posted by simmons

Auvi-Q; An Alternative to the EpiPen

Persons with potentially life-threatening allergic reactions to specific allergens (such as bee stings or certain foods) are told to carry an epinephrine auto-injector with them at all times.  A typical epinephrine auto-injector (such as an EpiPen) is a device about 5 ½ inches in length by one inch in diameter containing a single dose of injectable epinephrine.  When an allergic reaction occurs, the user is supposed to inject the epinephrine into his/her thigh as soon as possible.  I carried an EpiPen myself for a time, after I suffered a severe allergic reaction to multiple stings by ground-dwelling yellow jacket wasps.  But as time went by I stopped carrying it because it just didn’t seem necessary, and because carrying it every day was inconvenient.  Fortunately, I’ve never had another severe allergic reaction like that first one.  But what if I did?

Now there’s an alternative, called Auvi-Q.  Auvi-Q is still just a single dose of injectable epinephrine.  But Auvi-Q is shaped entirely differently; it’s about the length and width of a credit card and the width of a smart-phone.  The manufacturer hopes that it will appeal to the younger generation used to carrying credit/debit cards and phones.  More importantly, once the cover is removed Auvi-Q talks the user through the entire process of injection with a soothing human voice. (To hear the instructions, view the video on the Auvi-Q website.)  The verbal instructions may be helpful to some users and caregivers, since it may be years before the device is needed and one could forget how to use the device in that time.

The maker of Auvi-Q hopes that younger persons will find the device “cool”, and so perhaps they’ll be more willing to carry it than the EpiPen.  (The manufacturer of the EpiPen takes issue with an Auvi-Q marketing claim that 2/3 of EpiPen users don’t actually carry their EpiPen with them.)  Time will tell whether Auvi-Q is different enough to find a place in the competitive epinephrine auto-injector market.

Source:
http://humanbiologyblog.blogspot.com/2013/03/auvi-q-alternative-to-epipen.html

Recommendation and review posted by Bethany Smith

Cloning Goes Commercial

The first adult animal to be cloned was Dolly the sheep.   At the time (1997) the event was seen as a remarkable technological feat, of importance primarily to research biologists.   In the decade that followed other animals were cloned in research laboratories around the world.   Initial success rates were low, but in recent years the techniques have improved to the point that the cloning of adult animals is becoming economically feasible.

For example, a Texas company called Crestview Genetics is now in the business of cloning polo ponies.   Polo is a big sport in many countries, and good polo ponies are in great demand.  According to an article a polo trade journal, a three-month-old clone of a polo pony called Cuartetera sold for $800,000 in Argentina in 2010.  Crestview expects to be able to create up to 30 clones of valuable polo ponies and horses a year. You do the math.

Cloning animals for a profit is likely to become even more commonplace within the next decade.   The most likely candidates, obviously, are animals that are worth a lot to somebody, like prizewinning bulls for breeding cattle; championship dogs; rare or endangered animals; even beloved pets. How much would you be willing to pay to have your pet cloned?Source:
http://humanbiologyblog.blogspot.com/2013/02/cloning-goes-commercial.html

Recommendation and review posted by Bethany Smith

The Farrier’s Role with Stem Cell Therapy – Video


The Farrier #39;s Role with Stem Cell Therapy
At the 2013 International Hoof-Care Summit in Cincinnati, Ohio, Frank Reilly, DVM, talks about the farrier #39;s role in the use of stem cells.

By: AFJTV

Read more here:
The Farrier's Role with Stem Cell Therapy - Video

Recommendation and review posted by Bethany Smith

Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy – Video


Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy
Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy He is a known case of Myotonic MD with history of gradual onset of progressive lower extremities muscle weakness since age of 25 years. He also has history of delayed milestones. His weakness is progressive in nature. He falls while walking so walks with human support only. He has complaints of early fatigue and slurred speech due to tongue hypertrophy. He has atrophy of proximal muscles of all extremities. He has modified independence in almost all ADL. Neurologically, hypotonic, hyporeflexic. On examination: lower limb distal muscles are 0/5 on MMT while proximal muscles are having 2++/5 on MMT. Upper extremities left side proximal muscles are 1++/5 while right side proximal muscles are 3 #713;/5, distal muscles are 3++/5 in upper extremities. Functionally, modified independence in all ADL. On FIM he scores 99. After Stem Cell Treatment 1. His face looks more fresh. 2. His neck used to fall back previously but now he can control his neck well in each movement. 3. Back muscle strength has improved. 4. Bridging is better now. He can lift his back more up now which he couldn #39;t do at all. 5. His stamina has improved. 6. His shoulder strength has improved. Shoulder shrugging is better now. Active shoulder flexion, range of motion is more now. 7. Side lying to sitting he can do without any support which was not possible before. 8. Drooling of saliva from mouth in night is completely stopped. 9. His legs used ...

By: neurogenbsi

Go here to see the original:
Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy - Video

Recommendation and review posted by Bethany Smith

Cerebral Palsy Before and After Stem Cell Therapy Comparison – Video


Cerebral Palsy Before and After Stem Cell Therapy Comparison
Cerebral Palsy Before and After Stem Cell Therapy Comparison video Stem Cell Therapy done at Dr Alok Sharma NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur, Mumbai -- 71. Tel : 022 - 25283706, 022 - 25281610, Mob : +91 9920 200 400 http://www.neurogen.in http://www.stemcellsmumbai.com

By: neurogenbsi

Continue reading here:
Cerebral Palsy Before and After Stem Cell Therapy Comparison - Video

Recommendation and review posted by Bethany Smith

Stem Cell Therapy for Autism Part 2 – Video


Stem Cell Therapy for Autism Part 2
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy Psychology assessment: 1) Now his duration of expressing his anger has reduced (ie) previously he would get angry and it would continue for half an hour to 20 minutes. Now it has reduced to 10 minutes. 2) Now his level of understanding and tolerance level has increased (ie) before he would get upset even before his parents spoke whereas now he listens to them and follows commands. 3) Now he has started writing (ie) now he can copy from the book and he can do so for a duration of ½ hour to 1 hour which wasn #39;t possible at all before. 4) Previously he had obsessive features like washing his hands repetitively but now it has reduced. 5) Previously he would disturb others in the classroom by shouting or sitting next to them but now he doesn #39;t disturb others ...

By: neurogenbsi

Go here to read the rest:
Stem Cell Therapy for Autism Part 2 - Video

Recommendation and review posted by Bethany Smith

Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphereâ„¢ Cell Therapy

SALT LAKE CITY, Feb. 28, 2013 /PRNewswire/ --Discgenics announces the successful completion of an animal study demonstrating safety and efficacy of its novel therapy for reducing back pain caused by degenerative disc disease. This product, known as Injectable Discosphere Cell Therapy (IDCT), features Discgenics' patented, allogeneic, human disc-derived stem cell technology. The study showed that after one injection of IDCT in degenerated discs there was a restoration of disc height and tissue architecture, while noting no inflammatory response.

Discgenics CEO Flagg Flanagan said, " We are very encouraged by the results of the small animal pilot study as it shows the initial safety and efficacy of IDCT, which is produced from adult human disc-derived stem cells.We are optimistic that these early results will be indicative of our therapy's performance in further animal studies and will accelerate us toward human clinical studies and, ultimately, to an FDA cleared product.We believe this technology will revolutionize the way back pain is treated." Discgenics is currently conducting further studies of safety and efficacy in multiple animal species to support future scientific publications and for use in gaining regulatory clearance.

About Discgenics, Inc.

Discgenics is a privately funded spinal therapeutics company that is utilizing adult human disc stem cells within a tissue engineering approach to treat patients debilitated by degenerative disc disease. News and other information on the company are available at: http://www.discgenics.com.

Read more:
Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphereâ„¢ Cell Therapy

Recommendation and review posted by Bethany Smith

Prof. Jean-Marie Lehn at MU part 2 – Video


Prof. Jean-Marie Lehn at MU part 2
Nobel Laureate for Chemistry Prof. Jean-Marie Lehn #39;s lecture and dialogue "Supramolecular chemistry: Contributions to biotechnology and nanotechnology" on Friday, January 7, 2005 at the National Genetic Engineering and Biotechnology Center (BIOTEC) of the Ministry of Science and Technology at the Thailand Science Park, Rangsit

By: PeaceFoundationNET

See original here:
Prof. Jean-Marie Lehn at MU part 2 - Video

Recommendation and review posted by Bethany Smith

Prof. Jean-Marie Lehn at MU part 1 – Video


Prof. Jean-Marie Lehn at MU part 1
Nobel Laureate for Chemistry Prof. Jean-Marie Lehn #39;s lecture and dialogue "Supramolecular chemistry: Contributions to biotechnology and nanotechnology" on Friday, January 7, 2005 at the National Genetic Engineering and Biotechnology Center (BIOTEC) of the Ministry of Science and Technology at the Thailand Science Park, Rangsit

By: PeaceFoundationNET

Read the original:
Prof. Jean-Marie Lehn at MU part 1 - Video

Recommendation and review posted by Bethany Smith

Champion Drive Genetics – 2013 Sire Line-Up – Video


Champion Drive Genetics - 2013 Sire Line-Up
Champion Drive Genetics - 2013 Sire Line-Up - created at animoto.com

By: diamondgcattleco

Read the rest here:
Champion Drive Genetics - 2013 Sire Line-Up - Video

Recommendation and review posted by Bethany Smith

DoNUT Genetics – Video


DoNUT Genetics
THIS VIDEO IS DETICATED TO THE FOLLOWING (in alphabetical order)~ Chestersee D-trix of theDOMINICshow Grace Helbig of My Damn Channel Hannah Hart of My Drunk Kitchen Jenna Marbles Mamrie Hart of You Deserve a Drink MaxNoSleeves Ryan Higa of HigaTV, and nigahiga + many more Swoozie06 SO PLEASE!!! Watch it!! First video! Please bear with us Please please please watch it all the way through!!! Comments and subscriptions and kind criticism would be deeply appreciated. this was a video Conceived of and made within 2 hours. I #39;m sure you understand. PLEASE NOTE - We did not tag these youtube celebs for views/subscribers. We just love them very much and wanted them to see (and hopefully love) this video. THANK YOU SOOOO MUCH FOR WATCHING OUR AMATEURISHNESS!

By: AprilRosyChampagne59

Follow this link:
DoNUT Genetics - Video

Recommendation and review posted by Bethany Smith

Diabetes: What is it and how did I get it? – Video


Diabetes: What is it and how did I get it?
Dr. Kotansis understands that every patient has a unique set of symptoms, conditions, circumstances and needs. He will listen, investigate your history and research the interactions in your genetics, environment, lifestyle, and diet.

By: TheKotsanisInstitute

See original here:
Diabetes: What is it and how did I get it? - Video

Recommendation and review posted by Bethany Smith

10 Amazing Facts About Fungi – Video


10 Amazing Facts About Fungi
A fungus (pron.: / #712;f #652; #331; #609; #601;s/; plural: fungi[3] or funguses[4]) is a member of a large group of eukaryotic organisms that includes microorganisms such as yeasts and molds (British English: moulds), as well as the more familiar mushrooms. These organisms are classified as a kingdom, Fungi, which is separate from plants, animals, and bacteria. One major difference is that fungal cells have cell walls that contain chitin, unlike the cell walls of plants, which contain cellulose. These and other differences show that the fungi form a single group of related organisms, named the Eumycota (true fungi or Eumycetes), that share a common ancestor (a monophyletic group). This fungal group is distinct from the structurally similar myxomycetes (slime molds) and oomycetes (water molds). The discipline of biology devoted to the study of fungi is known as mycology (from the Greek mu; #973; kappa; eta; sigmaf;, muk #275;s, meaning "fungus"). Mycology has often been regarded as a branch of botany, even though it is a separate kingdom in biological taxonomy. Genetic studies have shown that fungi are more closely related to animals than to plants. Abundant worldwide, most fungi are inconspicuous because of the small size of their structures, and their cryptic lifestyles in soil, on dead matter, and as symbionts of plants, animals, or other fungi. They may become noticeable when fruiting, either as mushrooms or molds. Fungi perform an essential role in the decomposition of organic matter and have fundamental roles in ...

By: MovieMania1506

Excerpt from:
10 Amazing Facts About Fungi - Video

Recommendation and review posted by Bethany Smith

Why was Gregor Mendel Ignored? Genetics in the 1800s – DP 2.7 Blueprint of Life HSC Biology – Video


Why was Gregor Mendel Ignored? Genetics in the 1800s - DP 2.7 Blueprint of Life HSC Biology
The reasons of why Robert Mendel was ignored and not taken seriously in the 1800s for his experiments on heredity. This is a quick overview for HSC students studying dot point 2.7 of the blueprint of life syllabus

By: hscbiologyexposed

Continue reading here:
Why was Gregor Mendel Ignored? Genetics in the 1800s - DP 2.7 Blueprint of Life HSC Biology - Video

Recommendation and review posted by Bethany Smith

BJORN HEYHEIM – Video


BJORN HEYHEIM
Innovative solutions in genomics applications for sea bass and sea bream Athens, Greece, 11th October 2012 INTRANEMMA - MARINE GENOMICS for USERS Salmon aquaculture in Norway, breeding and genomics Bjørn Høyheim Norwegian School of Veterinary Science Department for Basic Sciences and Aquatic Medicine, Section for Genetics http://www.intranemma.eu

By: intranemma

Go here to see the original:
BJORN HEYHEIM - Video

Recommendation and review posted by Bethany Smith

Pedigree Charts – Video


Pedigree Charts
A simple description of how to create a pedigree chart in genetics.

By: Jennifer DesRochers

More:
Pedigree Charts - Video

Recommendation and review posted by Bethany Smith

LASER GENETICS DESIGNATOR ND3x50 – Video


LASER GENETICS DESIGNATOR ND3x50
I created this video with the YouTube Video Editor (www.youtube.com

By: erison bmx

View original post here:
LASER GENETICS DESIGNATOR ND3x50 - Video

Recommendation and review posted by Bethany Smith

Mandala Seeds : "Point Of No Return" *Cannabis Grow* Day 60 of Flower – Video


Mandala Seeds : "Point Of No Return" *Cannabis Grow* Day 60 of Flower
Just flushed with distilled water. Will harvest in 7-10 days. This was the mother plant I started from seed anddecided to flower because the genetics of clones were superior in quality and growth characteristics. I Highly Recommend Mandala Seeds! Point of No Return Type: indica/sativa Genetics: Afghanistan; Mexico Cultivation: indoor/outdoor/greenhouse THC: 15,5%, CBD: 0,5% High: Predominantly knockout medical-grade indica stone; couch lock; body relaxation. Aroma: Peppermint; sweet; fruity-berry; maracuja. Medical use: Deep and long lasting medical effects; suitable for pain relief, reducing MS related spasms, hyperactivity nervousness, anxiety, stress related symptoms, sleep disorders, menstrual cramps, muscle relaxant. Flowering time outdoor: mid-October (south), late October (north) Flowering time indoor: 65-72 days Recommended light intensity: 400-600W HPS/m2 Yield (dry weight): 350-400 gr/m2; 100+ gr. per plant in greenhouse; 700-1000 gr. per plant outdoor in the ground. Plant Height: medium Detailed Description: This exceptional medical strain should not be missing in any garden if you are looking for a one-hit wonder with a good yield and delicious aroma. Point of No Return (PNR) delivers a beautiful crop of thick cone-shaped buds crowned by towers of resiny calyxes. The long head bud tapers at the end like a peak and has a sufficiently airy structure that contributes to the high mold resistance. Although this is not a large plant it focuses a tremendous amount ...

By: rockyta21

Read more:
Mandala Seeds : "Point Of No Return" *Cannabis Grow* Day 60 of Flower - Video

Recommendation and review posted by Bethany Smith

Lot 12 1215 full brother – Video


Lot 12 1215 full brother
Homestead Genetics Bull Sale March 30 2013, full brother to Lot 12

By: Summerrain411

More here:
Lot 12 1215 full brother - Video

Recommendation and review posted by Bethany Smith


Archives